Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

Several Stoke-on-Trent criminals will be released early following a change made to prison sentences in order to tackle ...

Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...

Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Norwich City FC are all set to lock horns with Stoke City FC in match week 34 of the EFL Championship 2024-25 edition.

Norwich City are unbeaten across their past eight league games against Stoke City (W5 D3), scoring 3+ goals in four of those ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...